Try our Advanced Search for more refined results
Guardant Health, Inc. v. Foundation Medicine, Inc.
Case Number:
1:17-cv-01616
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 06, 2022
Delaware Judge Dismisses Guardant Cancer Test IP Suit
A Delaware federal judge Thursday dismissed Guardant Health Inc.'s suit against Foundation Medicine Inc. over cancer testing patents, closing out contentious litigation that included accusations of evidence destruction and a protracted battle over a settlement agreement.
-
November 18, 2020
Del. Judge Pushed Trial Due To Spoliation Claim, Not Virus
Delaware Chief U.S. District Judge Leonard Stark has explained that he delayed a trial in Guardant Health's patent infringement suit against Foundation Medicine earlier this month because of a "very serious" motion from Foundation alleging Guardant destroyed evidence, saying the postponement was not pandemic-related.
-
November 02, 2020
Guardant Patent Trial Delayed After Virus Safety Objections
A Delaware federal judge on Monday indefinitely postponed an in-person jury trial that was set for later this month in Guardant Health's infringement suit against Foundation Medicine Inc. over cancer testing patents, a scheduling change that comes on the heels of COVID-19 safety concerns raised by Foundation.
-
October 20, 2020
Health Care Co. Objects To Nov. Trial In Cancer Patent Fight
Foundation Medicine Inc. has objected to Delaware Chief U.S. District Judge Leonard Stark's scheduling of an in-person jury trial for Nov. 30 in Guardant Health's infringement suit against Foundation over cancer testing patents, pointing to a recent spike in coronavirus cases.
-
August 21, 2019
PTAB Will Review 2 Guardant Diagnostic Patents
The Patent Trial and Appeal Board has decided to review two Guardant Health Inc. diagnostic patents challenged by Foundation Medicine Inc. despite related post-grant reviews from last year and a looming infringement trial.